Original Query: ALL
Previous Study | Return to List | Next Study

A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00000836
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : October 25, 2012
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : August 1998